Physician profile
Darrell Thigpen
NPI 1467468785
$1,482.21
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,136 · 2020: $346.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $148.71 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $139.75 | 2019 | |
| Pfizer INC. | $137.06 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $130.33 | 2019-2020 | |
| Amarin Pharma, INC. | $121.82 | 2019-2020 | |
| Amgen INC. | $119.22 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $111.50 | 2019 | |
| Novartis Pharmaceuticals Corporation | $70.99 | 2019 | |
| Astellas Pharma US INC | $69.57 | 2019 | |
| Sanofi-Aventis U.S. LLC | $67.88 | 2019 | |
| Glaxosmithkline, LLC. | $48.13 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $47.76 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $40.09 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $34.17 | 2019 | |
| Arbor Pharmaceuticals, INC. | $26.66 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $21.99 | 2020 | |
| Allergan, INC. | $15.55 | 2019 | |
| Lilly USA, LLC | $13.72 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.12 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $11.73 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darrell Thigpen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.